Human IgM kit for use on SPAPLUS (2018-07-25) — recall 58157
Health Canada — Medical Devices · Canada · 2018-08-02 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Following the receipt of an external complaint a review was held at the binding site on 13/07/2018. Investigations at the binding site indicate that after running the calibration curve the recovery of the kit control results decrease by approximately 12% within the same day. Samples have been shown to be similarly affected.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.